Advocates Urge Government to Reimburse Life-Changing Medicine for Rare Disease

Advocates and politicians are pressing the government and the HSE to reimburse the cost of Skyclarys, a life-changing drug for Friedreich’s ataxia, as patients suffering from the rare disease plead for access to the medicine.